Topiramate for Binge Eating Disorder Among Adolescents
NCT00768677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2008-10-08
Summary
This is a study of topiramate to see whether topiramate decreases binge eating behavior among adolescents and young adults. The investigators did also checked whether topiramate affected cognitive function or not.
Conditions
- Eating Disorders
- Bulimia Nervosa
Interventions
- DRUG
-
topiramate
Sponsors & Collaborators
-
The Zucker Hillside Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 23 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
Countries
- United States
Study Locations
More Related Trials
-
Topiramate Augmentation in Bulimia Nervosa Partial Responders
NCT00988481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder
NCT01868204 ·Status: UNKNOWN
-
The Development of an Eating Laboratory for Overweight Adolescents
NCT00764127 ·Status: COMPLETED
-
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
NCT00308776 ·Status: TERMINATED ·Phase: NA
-
Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder
NCT06878976 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder
NCT01291173 ·Status: COMPLETED ·Phase: PHASE2
-
Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
NCT02659475 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
NCT03107026 ·Status: COMPLETED ·Phase: PHASE3
-
Craving, Binge Eating and Obesity
NCT00414167 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
NCT01038128 ·Status: COMPLETED ·Phase: NA
-
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
NCT05118906 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
NCT00330655 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
NCT04753164 ·Status: COMPLETED ·Phase: PHASE2
-
Vortioxetine for Binge Eating Disorder
NCT02528409 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating
NCT04088097 ·Status: COMPLETED ·Phase: NA
-
Pramipexole for Binge Eating Disorder
NCT01106053 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
NCT04154813 ·Status: UNKNOWN ·Phase: NA
-
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00277641 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Behavior Therapy for Adolescents With Bulimia
NCT00974038 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
NCT00320047 ·Status: COMPLETED ·Phase: NA
-
Atomoxetine in the Treatment of Binge Eating Disorder
NCT00327834 ·Status: COMPLETED ·Phase: PHASE4
-
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
NCT07042672 ·Status: RECRUITING
-
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
NCT03047005 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Folic Acid Supplementation in Eating Disorder
NCT01493674 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder
NCT01921582 ·Status: COMPLETED ·Phase: PHASE2